Synovial Fluid and Serum Inflammation Biomarkers After Autologous Matrix-Induced Chondrogenesis (AMIC) for Knee Chondral Defects
Journal of Clinical Medicine · 28.02.2026 · 15 (5) · 1874
DOI: 10.3390/jcm15051874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.02.2026. Verfasst von Adrian Urbanek und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.
Abstract (Originalsprache)
Background
Focal chondral and osteochondral knee defects have limited intrinsic healing capacity and may progress toward post-traumatic osteoarthritis. Early post-operative inflammatory signaling may influence clinical recovery after cartilage repair. This prospective, single-center observational cohort study aimed to characterize short-term post-operative inflammatory biomarker profiles in synovial fluid and serum after AMIC and to assess associations with patient-reported outcomes over 12 months.
Methods
Fifteen patients undergoing autologous matrix-induced chondrogenesis (AMIC) for focal knee chondral/osteochondral defects were prospectively enrolled. International Knee Documentation Committee (IKDC) and Lysholm scores were recorded pre-operatively and at 6 and 12 months. Synovial fluid and serum were collected intraoperatively, at 6 and 12 weeks post-operatively. Interleukin (IL)-1β, IL-1 receptor antagonist (IL-1RA), and IL-6 were quantified using multiplex flow luminescence immunoassay, and the total synovial fluid protein level was measured. Non-parametric repeated-measures testing and Spearman’s rank correlation were applied (p < 0.05).
Results
IKDC and Lysholm scores improved from (30.6 ± 9.4) to (58.8 ± 15.0) and from (57.5 ± 18.6) to (78.2 ± 14.7), respectively, exceeding established minimal clinically important difference (MCID) thresholds. Synovial fluid IL-1β and IL-1RA increased significantly over time ((p = 0.01357) and (p = 0.03953), respectively); IL-1β remained elevated, whereas IL-1RA tended to decline after 6 weeks. IL-6 levels remained low throughout. Total synovial fluid protein increased significantly (p = 0.00043). No significant correlations were observed between corresponding biomarker levels in synovial fluid and serum. Higher IL-6 and a higher IL-1β/IL-1RA ratio were associated with poorer clinical improvement (ρ = −0.80, p < 0.05 and ρ = −0.580, p < 0.05, respectively).
Conclusions
AMIC was associated with a sustained intra-articular inflammatory response despite favorable 12-month outcomes. Exploratory analyses suggest that inflammatory dysregulation—particularly involving IL-6 and IL-1β/IL-1RA balance—may be linked to less favourable clinical recovery. Synovial fluid measurements provided more relevant information on local joint biology than serum sampling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
- Department of Medical Rescue, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
- Department of Microbiology and Immunology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
- Department of Biophysics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
- Department of Pediatric Orthopedics and Traumatology, Municipal Hospital Complex, 41-500 Chorzów, Poland.
- Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
ORCID-Profile: Adrian Urbanek, Zenon Czuba, Paweł Dolibog, Paulina Zalejska-Fiolka, Jolanta Zalejska-Fiolka
Förderung
- Medical University of Silesia
Zitieren
APA
Urbanek, A., Wrotniak, M., Czuba, Z., Dolibog, P., Pilecki, G., Kostuj, M., Zalejska-Fiolka, P., & Zalejska-Fiolka, J. (2026). Synovial Fluid and Serum Inflammation Biomarkers After Autologous Matrix-Induced Chondrogenesis (AMIC) for Knee Chondral Defects. Journal of Clinical Medicine, 15(5), 1874. https://doi.org/10.3390/jcm15051874
Vancouver
Urbanek A, Wrotniak M, Czuba Z, Dolibog P, Pilecki G, Kostuj M, et al. Synovial Fluid and Serum Inflammation Biomarkers After Autologous Matrix-Induced Chondrogenesis (AMIC) for Knee Chondral Defects. Journal of Clinical Medicine. 2026;15(5):1874. doi:10.3390/jcm15051874
BibTeX
@article{Urbanek2026,
author = {Urbanek, Adrian and Wrotniak, Maciej and Czuba, Zenon and Dolibog, Paweł and Pilecki, Grzegorz and Kostuj, Marcin and Zalejska-Fiolka, Paulina and Zalejska-Fiolka, Jolanta},
title = {Synovial Fluid and Serum Inflammation Biomarkers After Autologous Matrix-Induced Chondrogenesis (AMIC) for Knee Chondral Defects},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {5},
pages = {1874},
doi = {10.3390/jcm15051874}
}
EUVIMED